These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 21078453)

  • 1. HIV drug resistance and mother-to-child transmission of HIV.
    Weidle PJ; Nesheim S
    Clin Perinatol; 2010 Dec; 37(4):825-42, x. PubMed ID: 21078453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
    Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.
    American Academy of Pediatrics Committee on Pediatric AIDS
    Pediatrics; 2008 Nov; 122(5):1127-34. PubMed ID: 18977995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral drugs to prevent breastfeeding HIV transmission.
    Mofenson LM
    Antivir Ther; 2010; 15(4):537-53. PubMed ID: 20587847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypic resistance tests for the management of the HIV-infected pregnant woman.
    Bassetti D; Cargnel A
    Scand J Infect Dis Suppl; 2003; 106():70-4. PubMed ID: 15000589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges.
    Kesho Bora Study Group
    Contemp Clin Trials; 2011 Jan; 32(1):74-85. PubMed ID: 20854932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of mother-to-child transmission of HIV: antiretroviral strategies.
    Read JS
    Clin Perinatol; 2010 Dec; 37(4):765-76, viii. PubMed ID: 21078449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mother-to-child transmission of HIV: pathogenesis, mechanisms and pathways.
    Kourtis AP; Bulterys M
    Clin Perinatol; 2010 Dec; 37(4):721-37, vii. PubMed ID: 21078446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 drug resistance and mother-to-child transmission.
    Morris L; Pillay C; Gray G; McIntyre J
    SADJ; 2001 Dec; 56(12):614-6. PubMed ID: 11887450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing mother-to-child transmission of HIV: successes and challenges.
    McIntyre J
    BJOG; 2005 Sep; 112(9):1196-203. PubMed ID: 16101596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso.
    Simpore J; Pietra V; Pignatelli S; Karou D; Nadembega WM; Ilboudo D; Ceccherini-Silberstein F; Ghilat-Avoid-Belem WN; Bellocchi MC; Saleri N; Sanou MJ; Ouedraogo CM; Nikiema JB; Colizzi V; Perno CP; Castelli F; Musumeci S
    J Med Virol; 2007 Jul; 79(7):873-9. PubMed ID: 17516517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on antiretroviral therapy.
    Riordan A; Bugembe T
    Arch Dis Child; 2009 Jan; 94(1):70-4. PubMed ID: 18838416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus infection and pregnancy.
    Petropoulou H; Stratigos AJ; Katsambas AD
    Clin Dermatol; 2006; 24(6):536-42. PubMed ID: 17113971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 mother-to-child transmission and prevention: successes and controversies.
    Cavarelli M; Scarlatti G
    J Intern Med; 2011 Dec; 270(6):561-79. PubMed ID: 21929711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infants of human immunodeficiency virus type 1-infected women in rural south India: feeding patterns and risk of mother-to-child transmission.
    Read JS; Samuel NM; Srijayanth P; Dharmarajan S; Van Hook HM; Jacob M; Junankar V; Bethel J; Yu E; Stoszek SK;
    Pediatr Infect Dis J; 2010 Jan; 29(1):14-7. PubMed ID: 19910839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.